Doxepin Hydrochloride

Product NDC
70518-3310
11-digit product format
705183310
Labeler code
70518
Product ID
70518-3310_d426e19f-c93b-782b-e053-2995a90a52ea
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Doxepin Hydrochloride
Dosage form
CAPSULE
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA213474
Marketing category
ANDA
Marketing start
2021-12-27
Marketing end
0000-00-00
Substance
DOXEPIN HYDROCHLORIDE
Active strength
25 mg/1
Pharmacologic classes
Tricyclic Antidepressant [EPC]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-3310-02023-03-24C16284748780-1f386c649-ae19-0266-e053-dadaa90a7c1a71105e9e-ca27-41d8-84e1-777df7290ac3
70518-3310-02023-01-30C16284748780-1f386c649-ae19-0266-e053-dadaa90a7c1a71105e9e-ca27-41d8-84e1-777df7290ac3

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-3310-07051833100030 CAPSULE in 1 BLISTER PACK (70518-3310-0) 30 capsule2021-12-270000-00-00NoNoCurrent